Telesis Bio (NASDAQ:TBIO) reported its Q3 earnings results on Monday, November 13, 2023 at 04:22 PM.
Here’s what investors need to know about the announcement.
Earnings
Telesis Bio missed estimated earnings by 23.33%, reporting an EPS of $-0.37 versus an estimate of $-0.3.
Revenue was down $1.11 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 5.76% drop in the share price the next day.
Here’s a look at Telesis Bio’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.37 | -0.41 | -0.48 |
| EPS Actual | -0.28 | -0.37 | -0.28 | -0.42 |
| Revenue Estimate | 8.60M | 7.40M | 7.20M | 5.30M |
| Revenue Actual | 8.65M | 6.32M | 9.47M | 6.67M |
To track all earnings releases for Telesis Bio visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
